• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ PANOPTIX TRIFOCAL IOL; LENS, MULTIFOCAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ PANOPTIX TRIFOCAL IOL; LENS, MULTIFOCAL Back to Search Results
Model Number TFNT00
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Corneal Edema (1791); Eye Injury (1845)
Date of Event 10/04/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A physician reported that during an intraocular lens (iol) implant procedure, the lens was introduced without pressure into the patient's eye chamber and when it was deposited, it released a dust, making it seem like the lens was peeling off and released a its haptic inside the eye, which the surgeon tried to fix the lens in position and could not, surgeon had to proceed to cut it for its extraction during initial procedure, causing a longer period of surgery and concern for the patient.Additional information has been received and stated that, there was damage to the patient, the patient still has very severe edema in the cornea and anterior chamber, detachment of decrement microparticles.The problem occurred during cataract surgery when the lens was implanted in the anterior chamber.When the iol finished entering, it released dust and one of its haptics became detached.The procedure was completed with another lens.
 
Additional Manufacturer Narrative
The lens was returned for evaluation.Solution is dried on the lens.The lens was returned in four pieces.Both haptics are broken in the gusset area.The optic is cut in half, typical of insertion and removal from the eye.Scratches are observed on the optic portions of the lens.A piece of edge material is broken off the optic.The returned lens matches the provided photo(s).A qualified cartridge and viscoelastic indicated.It is unknown if a qualified handpiece was used.Broken haptic damage was observed.All lenses are 100% inspected for cosmetic attributes and the damage exhibited by the returned complaint sample would not have met company release criteria.Based on our observation, it can be reasonably concluded that the damage is not manufacturing related.Due to the presence of surgical solution and the condition of the returned sample, the damage is most likely related to customer handling.It is unknown if a qualified handpiece was used.The ifu instructs: company foldable iols are qualified for use with an company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The ifu (instructions for use) instructs that an company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.The ifu instructs: using holding forceps, grasp the lens by the optic edge and gently place the lens anterior side up into the back of the ophthalmic viscosurgical device (ovd)-filled cartridge.The lens should be inserted until the optic is a little more than half-way inside the cartridge.Use the holding forceps to gently push down on the lens, verifying that the lens is on the bottom surface of the cartridge.Using holding forceps, take the trailing haptic, and gently fold the haptic onto the anterior side of the optic.Slowly grip or push the optic edge to position the lens as far into the cartridge as the forceps will permit, while ensuring the lens remains on the bottom surface of the cartridge and the trailing haptic remains on the optic.Failure to follow these steps may cause the lens to advance incorrectly causing delivery issues and/or damage.Information was provided that stated the lens was implanted into the anterior chamber.It is unclear if this may have been a contributory factor as the company lens is intended for placement into the posterior chamber.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ PANOPTIX TRIFOCAL IOL
Common Device Name
LENS, MULTIFOCAL
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17984911
Report Number1119421-2023-01808
Device Sequence Number18209968
Product Code MFK
UDI-Device Identifier00380652357807
UDI-Public00380652357807
Combination Product (Y/N)N
Initial Reporter CountryPE
PMA/510(K) Number
P040020
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberTFNT00
Device Catalogue NumberTFNT00.235
Device Lot Number15506229
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/06/2023
Supplement Date Received by Manufacturer12/17/2023
Initial Report FDA Received Date10/23/2023
Supplement Report FDA Received Date01/10/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/07/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DUOVISC; MONARCH III CARTRIDGE D; PROVISC; VISCOAT
Outcome Attributed to Adverse Event Other;
Patient Age63 YR
Patient SexMale
-
-